Generally, for patients with T2 stage operable HR + /HER2- breast cancer, primary surgery followed by ACT is preferred over NACT due to the relatively low rate of pathologic complete response (pCR) with NACT [15]. This evidence concerns the gene ERBB2 and breast cancer.